Johnson Matthey PLC (LON:JMAT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is GBX 2,221.43 ($28.48).
Several equities research analysts have issued reports on JMAT shares. Deutsche Bank Aktiengesellschaft upgraded shares of Johnson Matthey to a “buy” rating and lifted their target price for the company from GBX 2,300 ($29.49) to GBX 2,500 ($32.06) in a research report on Monday, July 17th. Numis Securities reiterated a “buy” rating and set a GBX 2,400 ($30.77) target price on shares of Johnson Matthey in a research report on Monday, May 22nd. Jefferies Financial Group reissued a “buy” rating and set a GBX 2,200 ($28.21) price target on shares of Johnson Matthey in a research note on Tuesday, June 27th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 2,200 ($28.21) price target on shares of Johnson Matthey in a research note on Tuesday, May 30th.
Johnson Matthey Stock Performance
LON JMAT opened at GBX 1,820 ($23.34) on Monday. Johnson Matthey has a 52-week low of GBX 1,658 ($21.26) and a 52-week high of GBX 2,384 ($30.57). The company has a 50-day simple moving average of GBX 1,767.88 and a 200 day simple moving average of GBX 1,960.08. The company has a debt-to-equity ratio of 66.29, a quick ratio of 0.76 and a current ratio of 1.51. The company has a market capitalization of £3.34 billion, a PE ratio of 1,263.89, a price-to-earnings-growth ratio of 49,242.50 and a beta of 1.02.
Johnson Matthey Increases Dividend
Insiders Place Their Bets
In other Johnson Matthey news, insider Liam Condon purchased 21 shares of the company’s stock in a transaction on Wednesday, July 19th. The stock was acquired at an average cost of GBX 1,849 ($23.71) per share, for a total transaction of £388.29 ($497.87). 0.29% of the stock is currently owned by corporate insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MarketBeat Week in Review – 7/24 – 7/28
- Crypto vs Stocks: How to Choose Your Investments
- Can SAIA Continue its Stratospheric Rally?
- How to Invest in Energy
- Why Markets Are Loving Exxon Mobil, Despite The Earnings Dip
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.